A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2004
11/04/2004	US20040220104 Meconium aspiration syndrome treatments
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219224 Spherical protein particles and methods for making and using them
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219201 Tempamine compositions and methods of use
11/04/2004	US20040219165 Streptococcus pneumoniae antigens
11/04/2004	US20040219144 administering an anti-human NGF monoclonal antibody capable of binding hNGF with an affinity in the nanomolar range, and inhibiting the binding of hNGF to human TrkA (hTrkA) in vivo, wherein said antibody has no significant adverse effect on the immune system
11/04/2004	US20040219107 The applicator assembly includes a sleeve that encases a swab having a portion that contacts a gelled composition; the sleeve is manually severed to expose the applicator and the composition
11/04/2004	US20040219106 Compounds for use as surfactants
11/04/2004	DE10315931A1 Verfahren zur Herstellung eines Extraktes aus Efeublättern A process for producing an extract of ivy leaves
11/04/2004	CA2523048A1 4-, 6- o 7-hydroxyindoles having n-oxide groups and the use thereof as therapeutic agents
11/04/2004	CA2522300A1 Treatment of angiotensin ii related disease
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1473302A1 HETEROCYCLIC COMPOUNDS HAVING ELASTASE−INHIBITING ACTIVITY AND INTERMEDIATES THEREOF
11/03/2004	EP1473295A1 Fused bicyclic pyrimidine derivatives
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472251A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
11/03/2004	EP1472250A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
11/03/2004	EP1472249A1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
11/03/2004	EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1472222A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471919A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
11/03/2004	EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases
11/03/2004	EP1471900A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions
11/03/2004	EP1471896A1 Formulations for inhalation
11/03/2004	EP1471895A1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
11/03/2004	EP1471884A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
11/03/2004	EP1471872A2 Treatment of colds and cough with a combination of a cyclooxygenase-2 selective inhibitor and a colds and cough active ingredient and compositions thereof
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1347974B1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
11/03/2004	EP1339716B1 lactam-substituted pyrazolopyridine derivatives
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors
11/03/2004	EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004	EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004	EP0923376B1 Use of steroids for treatment of asthma and airway diseases
11/03/2004	EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/03/2004	CN1543504A 疫苗 Vaccine
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543345A Methods for selective immunomodulation using pimecrolimus
11/03/2004	CN1543338A Chitin microparticles and their medical uses
11/03/2004	CN1542006A Salt of phenylacetyl-(N-methyl)leucine-aspartic acid- phenylalanine-(N-methyl)piperazine
11/03/2004	CN1541707A Medicinal composition for treating serious acute respiratory syndrome
11/03/2004	CN1541689A Manufacturing technique of fine Fanhuncao granula formulation
11/03/2004	CN1541660A Antipyretic antitussive
11/03/2004	CN1541652A Traditional Chinese medicine for treating upper respiratory tract infection and its preparation method
11/03/2004	CN1541650A Chronic bronchitis treating traditional Chinese medicine
11/03/2004	CN1541648A Sodium bisulfate andrographolide aseptic powder for injection and its preparation method
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173950C 2,3-Disubstituted pyridine derivatives, process for preparation thereof, drug compositions containing the same and intermediates for preparation
11/03/2004	CN1173731C Use of Traditonal Chinese medicine composition for curing chronic hepatitis B fibrosis in preparation of medicine for pulmonary fibrosis of SARS
11/03/2004	CN1173713C Method for producing nasopharynx disease pill
11/03/2004	CN1173702C Glucocorticoid containing pharmaceutical inhalant powder and method for sterilizing the powder
11/03/2004	CN1173697C Aniline disulfide derivatives for treating allergic diseases
11/03/2004	CN1173695C Controlled release and odor masking oral pharmaceutical compositions
11/02/2004	US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004	US6811796 Administering plant extracts; health food
11/02/2004	US6811767 Liquid droplet aerosols of nanoparticulate drugs
11/02/2004	US6810874 Two or more powder containers for different drug powders which can be inhaled as a combined medication
11/02/2004	CA2338704C Oral liquid mucoadhesive compositions
11/02/2004	CA2315614C Pyrazoles
11/02/2004	CA2296970C Neuropeptide y antagonists
11/02/2004	CA2283676C Stimulation, culture and preservation of pancreatic and other cells
11/02/2004	CA2129040C Styryl derivatives and processes for their preparation
11/02/2004	CA2112014C Antiallergic composition for ophthalmic or nasal use
10/2004
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004092169A1 Spiropiperidine compound and medicinal use thereof
10/28/2004	WO2004092136A1 Nitrogenous heterocyclic compound and use thereof
10/28/2004	WO2004091610A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
10/28/2004	WO2004091607A1 Quaternary ammonium compounds and their use as antimuscarinic agents
10/28/2004	WO2004091606A1 Treatment of bronchial asthma using 5-ht3 receptor antagonists
10/28/2004	WO2004091576A1 Formulations and methods for treating rhinosinusitis
10/28/2004	WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/28/2004	WO2004064716A3 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders
10/28/2004	WO2004047925A3 Therapeutic oxidation catalysts
10/28/2004	WO2003105908A3 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
10/28/2004	WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004	WO2003030833A3 Angiopoietin-2 specific binding agents
10/28/2004	US20040215023 Crystal and process for producing the same
10/28/2004	US20040215014 Auroyl cyclic amines for controlling behavior or appetite

1 ... 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 ... 878